We are monitoring the impact of COVID-19 & Recession alarm on MEA Pancreatic Cancer Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Pancreatic Cancer Market Research Report – Segmented By Treatment Type, Cancer Type, End Users & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1208
Pages: 179

MEA Pancreatic Cancer Market Size (2022 to 2027)

The size of the Pancreatic Cancer Market in the Middle East and Africa was worth USD 0.21 billion in 2022 and is estimated to be growing at a CAGR of 6.865 %, to reach USD 0.30 billion by 2027.

Pancreatic cancer is one of the most common cancers in males leading to death due to aggressive metastatic growth and complications. The presence of several risk factors with co-morbidities increases the incidence rate of pancreatic cancer. The overall pancreatic cancer death rate in Egypt was reported at 1.48 / 100,000 population, and analysis of the regional distribution showed significant variations in rates between provinces, with the northern provinces having higher rates than those in the southern. The cancer prevalence in Saudi Arabia is recorded at 2.25/100,000, with an annual death rate of 1.64/100,000. Based on these same reports, the majority in males is at 2.75/100,000 and 1.69/100,000 in women.

Advances in technology and medicine are opening up new opportunities for physicians and other healthcare providers to treat pancreatic cancer better. Early diagnosis and intervention are seen to have better results. According to one report, only 13% to 16% of patients are diagnosed early enough to be treated with surgery, drugs, and chemotherapy. Latest diagnostic tests and therapeutics modalities are helping to fight this cancer with fewer side effects. Increased alcohol use, obesity, drug addiction, and smoking, and the growing rate of the geriatric population will increase the rate of pancreatic cancer in the Middle East and African region.

However, several factors are responsible for hampering the market's growth rate. Factors such as the lack of healthcare facilities, limited treatment options, absence of whole coverage insurance policies, and low success rates in clinical trials of cancer drugs will be responsible for restraining the market in the years to come. Moreover, the poor economic status of developing and developing regions in the MEA region challenges the growth of the MEA pancreatic cancer market.

This research report on the MEA pancreatic cancer market has been segmented & sub-segmented into the following categories:

By Treatment Type:

  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • Others

By Cancer Type:

  • Exocrine Pancreas Cancer
  • Endocrine Pancreas Cancer

By End User:

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the MEA pancreatic cancer treatment market is estimated to post commendable gains by the end of 2027, mainly dominated by the revenues generated in Saudi Arabia, the United Arab Emirate, followed by Qatar.

In 2020, the Saudi Arabian regional market had experienced respectable growth in the Middle East and Africa pancreatic cancer market. This regional market growth can be attributed to increased funds for research and development, supportive reimbursement policies, and the presence of technologically advanced diagnostic and treatment options to tackle this aggrieve type of cancer. In addition, supportive government activities in the form of campaigns, camps, surveys, and studies raise awareness about pancreatic cancer among the Saudi Arabian population in the years to come.

The unmet market demand related to the disease drives many multinational companies to invest in the African region. In addition, the large patient population, public awareness of the disease and symptoms, and the continued efforts by regional authorities will drive the market in this region, especially in South Africa.

Qatar and the United Arab Emirates are predicted to post a healthy growth rate during the forecast period. Factors such as improving healthcare infrastructure, growing demand for high-quality healthcare, and increased expenditure are estimated to boost the CAGR during the forecasted period.

KEY MARKET PLAYERS:

Eli Lilly, Amgen, Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc., and NewLink Genetics Corp. are playing a leading role in the MEA Pancreatic Cancer Market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type of Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Surgery    

                                5.1.3 Chemotherapy     

                                5.1.4 Radiation Therapy

                                5.1.5 Others      

                                5.1.6 Y-o-Y Growth Analysis, By Type of Treatment          

                                5.1.7 Market Attractiveness Analysis, By Type of Treatment         

                                5.1.8 Market Share Analysis, By Type of Treatment          

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Exocrine Pancreas Cancer

                                5.2.3 Endocrine Pancreas Cancer              

                                5.2.4 Y-o-Y Growth Analysis, By Type      

                                5.2.5 Market Attractiveness Analysis, By Type     

                                5.2.6 Market Share Analysis, By Type      

                5.3 End-users                   

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Research Institutes             

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End-users            

                                5.3.7 Market Attractiveness Analysis, By End-users          

                                5.3.8 Market Share Analysis, By End-users           

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type of Treatment

                                                6.1.3.3 By Type

                                                6.1.3.4 By End-users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type of Treatment

                                                6.1.4.3 By Type

                                                6.1.4.4 By End-users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type of Treatment

                                                6.1.5.3 By Type

                                                6.1.5.4 By End-users

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Eli Lilly                           

                                8.1.1 Overview

                                8.1.2 Type of Product    

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen, Inc.                

                8.3 Celgene Corp.                           

                8.4 F. Hoffmann-La Roche                           

                8.5 Clovis Oncology Inc.                

                8.6 Pfizer                            

                8.7 Novartis AG                

                8.8 Threshold Pharmaceuticals Inc.                          

                8.9 Aduro BioTech Inc.                  

                8.10 Infinity Pharmaceuticals Inc.                             

                8.11 NewLink Genetics Corp.                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Middle East & Africa Pancreatic Cancer Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  2. Middle East & Africa Surgery Market, By Region, From 2022 - 2027 (USD Billion)
  3. Middle East & Africa Chemotherapy Market, By Region, From 2022 - 2027 (USD Billion)
  4. Middle East & Africa Radiation Therapy Market, By Region, From 2022 - 2027 (USD Billion)
  5. Middle East & Africa Others Market, By Region, From 2022 - 2027 (USD Billion)
  6. Middle East & Africa Pancreatic Cancer Market, By Type, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa Exocrine Pancreas Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Endocrine Pancreas Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Pancreatic Cancer Market, By End-users, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  11. Middle East & Africa Clinics Market, By Region, From 2022 - 2027 (USD Billion)
  12. Middle East & Africa Research Institutes Market, By Region, From 2022 - 2027 (USD Billion)
  13. Middle East & Africa Others Market, By Region, From 2022 - 2027 (USD Billion)
  14. Middle East Pancreatic Cancer Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  15. Middle East Pancreatic Cancer Market, By Type, From 2022 - 2027 (USD Billion)
  16. Middle East Pancreatic Cancer Market, By End-users, From 2022 - 2027 (USD Billion)
  17. Africa Pancreatic Cancer Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  18. Africa Pancreatic Cancer Market, By Type, From 2022 - 2027 (USD Billion)
  19. Africa Pancreatic Cancer Market, By End-users, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample